PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitorsBrian D. Lehmann, Jennifer A. Pietenpol|Breast Cancer Research|2014Cited by 331
TNBCtype: A Subtyping Tool for Triple-Negative Breast CancerXi Chen, Jennifer A. Pietenpol, Joshua A. Bauer et al.|Cancer Informatics|2012Cited by 303
Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypesBrian D. Lehmann, X. Steven Chen|Nature Communications|2021Cited by 255
Comparison of triple-negative breast cancer molecular subtyping using RNA from matched fresh-frozen versus formalin-fixed paraffin-embedded tissueBojana Jovanović, Brian D. Lehmann|BMC Cancer|2017Cited by 54